The 2017 ICSA China Conference in Jilin invites applications for Junior Researcher Award. Awardees will be selected from junior researchers who submit their papers for presentations at the conference in Jilin. This award will be sponsored by Biostatistics & Data Sciences Department at Boehringer Ingelheim (BI). Students or Junior Researchers who received their degrees no earlier than March 31, 2012 are encouraged to submit a research paper in topics on either methodological research, novel application of statistical methods to problems in other disciplines, or other suitable contributions to biostatistics and data sciences. Jointly authored papers are acceptable, but the applicant is expected to be the lead author and present the work in the meeting.
Formal application consists of sending an e-mail to Dr. Jiang at firstname.lastname@example.org with the subject title as "Application - 2017 ICSA China Conference Junior Researcher Award" with the following attachments (in PDF):
1. The curriculum vita of the applicant
2. The manuscript of the completed research
Please apply for the award no later than May 28, 2017.
Papers will be reviewed and five winners will be selected by a committee of the ICSA China Conference. Criteria for selection will include, but are not limited to, novelty in theory/methods/applications, significance and potential impact of the research, and clarity of writing and presentation. Each winner will be awarded a certificate and a RMB 2000 travel funding. The award will be presented to the winners during the Banquet on July 3, 2017.
Boehringer Ingelheim is the world's largest family-owned pharmaceutical company and ranks among the world's top 20 leading pharmaceutical companies. Since 1885, the Company has been committed to developing, manufacturing and marketing innovative medicines that feature a high therapeutic value for humans and animals. In Boehringer Ingelheim, we regard employees as the greatest treasure, and firmly commit to ensuring a safe, healthy, productive and efficient work environment for our employees, partners and customers.
Biostatistics & Data Sciences (BDS) at BI is a global organization providing state-of-the-art expertise using analytics, methodologies and applications in the drug development lifecycle at BI. We partner with internal and external customers to transform data into knowledge for decision making to benefit patients. BDS has three regional operating units worldwide including BDS Asia, BDS US and BDS Europe.